| Date | Title | Description | Source |
| 25.01.2024 | Another step toward new drugs for Parkinson’s | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 15.02.2022 | Kallyope scores $236M, Ro scoops up $150M and more digital h... | Photo: Kwanchai Lerttanapunyaporn/EyeEm/Getty Images | mobihealth... |
| 15.02.2022 | Kallyope Secures $236M Series D Funding |
NEW YORK, NY, Kallyope today announced the closing of a $236 million Series D financing round.
&g... | vcnewsdail... |
| 15.02.2022 | Kallyope Raises $236M in Series D Financing | Kallyope, Inc., a NYC-based biotechnology company focused on identifying and developing therapeutics... | finsmes.co... |
| 15.02.2022 | Kallyope, with ex-Merck exec at helm, skirts 'less desirable... | When former Merck Chief Development Officer Jay Galeota joined Kallyope in August 2021, the plan was... | fiercebiot... |
| 14.01.2022 | Our 2021 Predictions Report Card: How Accurate Were We? | Each year we pause to reflect on what happened in the tech and VC space and share new predictions fo... | twosigmave... |
| 05.08.2021 | Kallyope Announces CEO Transition as Company Advances to its... | | prnewswire... |
| 25.03.2020 | Kallyope Announces $112M Series C Round |
NEW YORK, NY, Kallyope announced a $112 million Series C financing.
>> Click here for more ... | vcnewsdail... |
| 25.03.2020 | Kallyope Raises $112M in Series C Financing | Kallyope Inc., a NYC-based biotechnology company focused on identifying and pursuing therapeutic opp... | finsmes.co... |
| 25.03.2020 | Gut-brain biotech Kallyope sets sights on the clinic with $1... | Kallyope set out in 2015 with $44 million and a mission to map out the “information highway” between... | fiercebiot... |
| 25.03.2020 | Kallyope Announces $112M Series C | Kallyope Inc., a leading biotechnology company focused on identifying and pursuing therapeutic oppor... | citybizlis... |
| 25.03.2020 | Gut-brain biotech Kallyope sets sights on the clinic with $1... | Kallyope set out in 2015 with $44 million and a mission to map out the “information highway” between... | fiercebiot... |
| 17.04.2019 | As researchers pursue links between bacteria and human healt... | In 2009, the National Institutes of Health launched a five-year, $150 million project to stimulate r... | techcrunch... |
| 05.12.2018 | Kallyope Announces $21 Million Expansion of Series B Financi... | Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities invo... | citybizlis... |
| 05.12.2018 | Kallyope Announces $21M Expansion of Series B |
NEW YORK, NY, Biotechnology company focused on identifying therapeutic opportunities involving the... | vcnewsdail... |
| 05.12.2018 | Kallyope Raises $21M Expansion of Series B Financing | Kallyope Inc., a NYC-based biotechnology company focused on identifying therapeutic opportunities in... | finsmes.co... |
| 22.02.2018 | Term Sheet — Thursday, February 22 | THE KING OF RIDE-HAILING
Good morning, Term Sheet readers.
Paid Content Securing the enterprise with... | fortune.co... |
| 22.02.2018 | Kallyope Raises $66M Series B | Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities invo... | citybizlis... |
| 22.02.2018 | Gut-brain biotech Kallyope ramps up, bags $66M series B | Columbia University spinout Kallyope launched back in 2015 with $44 million and a mission: to unders... | fiercebiot... |
| 22.02.2018 | Kallyope Raises $66M |
NEW YORK, NY, Kallyope today announced a $66 million Series B financing and significant progress i... | vcnewsdail... |
| 22.02.2018 | Kallyope Raises $66M in Series B Financing | Kallyope Inc., a NYC-based biotechnology company focused on identifying therapeutic opportunities in... | finsmes.co... |
| 22.02.2018 | Kallyope Raises $66M Series B | Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities invo... | archive.ci... |
| 16.10.2017 | Illumina Ventures Founder talks about investment priorities ... | Illumina Ventures Founder Nicholas Naclerio responded to questions about its investment strategy and... | medcitynew... |
| 28.02.2017 | Lux Capital closes $400 million fund to back startups ‘inven... | Lux Capital’s portfolio companies sound like they ripped their product concepts from the pages of sc... | techcrunch... |
| 28.02.2017 | As Lux Capital raises $400M fund, partner answers question: ... | Some examples of previous healthcare and life science investments include care coordinator via teleh... | medcitynew... |
| 30.11.2016 | Axial Biotherapeutics raises $19.15M to target gut-brain axi... | This builds on an array of preclinical research that has shown a link between gut bacteria and neuro... | medcitynew... |
| 10.12.2015 | In a win for NYC, gut-brain biotech Kallyope launches with $... | Kallyope CEO Nancy Thornberry
New York's ambitious plans to grow a biotech hub in the heart of its w... | fiercebiot... |
| 10.12.2015 | Kallyope Launches with $44M in Series A Funding | Kallyope, Inc., a New York City-based biotech company focused on harnessing the potential of the gut... | finsmes.co... |
| 10.12.2015 | Kallyope launches with $44M to study gut-brain connection | “There’s increasing interest also in making compounds restricted to the gut, that actually can be us... | medcitynew... |
| - | As Lux Capital raises $400M fund, partner answers question: ... | Early stage venture capital investor Lux Capital announced via blog post that it had raised a $400 m... | medcitynew... |
| - | Axial Biotherapeutics raises $19.15M to target gut-brain axi... | A new therapeutic microbiome company was officially launched on Wednesday, with the help of a $19.15... | medcitynew... |
| - | Kallyope Announces a $66M Series B to Develop Drugs Targetin... | We’re excited to announce today that Two Sigma Ventures is joining Euclidean Capital, Lux Capital, T... | twosigmave... |
| - | The Path to Precision Medicine | We believe data-driven companies can create the most powerful solutions to our world’s biggest probl... | twosigmave... |
| - | Illumina Ventures Founder talks about investment priorities ... | Early stage genomics businesses are the focus of Illumina Ventures’ first fund. Launched last year a... | medcitynew... |
| - | Kallyope launches with $44M to study gut-brain connection | Scientists are beginning to unravel the connection between the brain and the stomach – finding there... | medcitynew... |
| - | Kallyope Raises Another $112M to Map Out the Gut-Brain Axis ... | 501SHARES
FacebookTwitter
Linkedin
Rising obesity rates in the United States are a major health conc... | alleywatch... |
